Acceptability of innovative culture-based antibiotic prophylaxis strategies: a multi-method study on experiences regarding transrectal prostate biopsy
Authors:
Open Access
- 17 November 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 3 (4) , dlab161
Abstract
The acceptability of innovative medical strategies among healthcare providers and patients affects their uptake in daily clinical practice. To explore experiences of healthcare providers and patients with culture-based antibiotic prophylaxis in transrectal prostate biopsy with three swab-screening scenarios: self-sampling at home, self-sampling in the hospital and sampling by a healthcare provider. We performed focus group interviews with urologists and medical microbiologists from 11 hospitals and six connected clinical microbiological laboratories. We used Flottorp’s comprehensive checklist for identifying determinants of practice to guide data collection and analysis. The experiences of 10 laboratory technicians from five laboratories and 452 patients from nine hospitals were assessed using a questionnaire. Overall, culture-based prophylaxis strategies were experienced as feasible in daily clinical practice. None of the three swab-screening scenarios performed better. For urologists (n = 5), implementation depended on the effectiveness of the strategy. In addition, it was important to them that the speed of existing oncology care pathways is preserved. Medical microbiologists (n = 5) and laboratory technicians (n = 8) expected the strategy to be fairly easy to implement. Patients (n = 430; response rate 95.1%) were generally satisfied with the screening scenario presented to them. To meet the various patients’ needs and preferences, multiple scenarios within a hospital are probably needed. This multi-method study has increased our understanding of the acceptability of culture-based prophylaxis strategies in prostate biopsy, which can help healthcare providers to offer high-quality patient-centred care. The strategy seems relatively straightforward to implement as overall acceptance appears to be high.Keywords
Funding Information
- Netherlands Organisation for Health Research and Development (541001009)
This publication has 16 references indexed in Scilit:
- Feasibility and Acceptability of Anal Self-Sampling for Human Papillomavirus Screening in HIV-Infected PatientsIntervirology, 2016
- Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?Advances in Urology, 2016
- The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography‐guided prostate biopsy in reducing infection rates: a systematic reviewBJU International, 2016
- Antimicrobial resistance: a global multifaceted phenomenonPathogens and Global Health, 2015
- Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-AnalysisPLOS ONE, 2015
- Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El SalvadorInternational Journal of Gynecology & Obstetrics, 2014
- A checklist for identifying determinants of practice: A systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practiceImplementation Science, 2013
- Infective Complications After Prostate Biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, A Prospective Multinational Multicentre Prostate Biopsy StudyEuropean Urology, 2013
- Antibiotic Prophylaxis in Urologic Procedures: A Systematic ReviewEuropean Urology, 2008
- Self-Sampling for Group B Streptococcus in Women 35 to 37 Weeks Pregnant Is Accurate and Acceptable: A Randomized Cross-Over TrialJournal of Obstetrics and Gynaecology Canada, 2006